Inventor · disambiguated record
Ramy Lidor-Hadas
Also filed as: LIDOR-HADAS RAMY
17 granted patents·9 pending applications·443 citations·filing 1999–2021
95Inventor score
Top patents by PatentIndex Score
26 records- 0196US7619117B1Rasagiline formulations and processes for their preparationTEVA PHARMA·Filed 2008·Granted Nov 17, 2009·39 cites·11 claims
- 0294US7598420B1Rasagiline formulations and processes for their preparationTEVA PHARMA·Filed 2008·Granted Oct 6, 2009·46 cites·20 claims
- 0394US7572834B1Rasagiline formulations and processes for their preparationTEVA PHARMA·Filed 2006·Granted Aug 11, 2009·49 cites·12 claims
- 0494US6696600B2L-DOPA ethyl ester salts and uses thereofTEVA PHARMA·Filed 2002·Granted Feb 24, 2004·42 cites·20 claims
- 0593US6528661B2Hydrolysis of [R(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino) carbonyl]-1H-pyrrole-1-heptanoic acid esters with calcium hydroxideTEVA PHARMA·Filed 2001·Granted Mar 4, 2003·64 cites·22 claims
- 0692US7491847B2Methods for isolating propargylated aminoindansTEVA PHARMA·Filed 2006·Granted Feb 17, 2009·55 cites·37 claims
- 0792US7342120B2Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other formsTEVA PHARMA·Filed 2005·Granted Mar 11, 2008·6 cites·1 claims
- 0891US6605636B2Atorvastatin hemi-calcium form VIITEVA PHARMA·Filed 2001·Granted Aug 12, 2003·55 cites·17 claims
- 0989US6992194B2Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other formsTEVA PHARMA·Filed 2004·Granted Jan 31, 2006·16 cites·18 claims
- 1084US7144916B2Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other formsTEVA PHARMA·Filed 2004·Granted Dec 5, 2006·7 cites·13 claims
- 1181US7468444B2Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other formsTEVA PHARMA·Filed 2005·Granted Dec 23, 2008·1 cites·8 claims
- 1280US10047049B2Process for preparing pridopidineBarel Offir·Filed 2016·Granted Aug 14, 2018·13 cites·24 claims
- 1380US6696601B2Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereofTEVA PHARMA·Filed 2001·Granted Feb 24, 2004·11 cites·37 claims
- 1479US6201148B1Process for preparing alendronic acidTEVA PHARMA·Filed 2000·Granted Mar 13, 2001·13 cites·22 claims
- 1575US6963008B2Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereofTEVA PHARMA·Filed 2003·Granted Nov 8, 2005·8 cites·2 claims
- 1669US7488750B2Crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other formsTEVA PHARMA·Filed 2005·Granted Feb 10, 2009·0 cites·9 claims
- 1768US2008214650A1Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel process for preparing other formsARONHIME JUDITH·Filed 2007·Application pending·0 cites
- 1866US6281381B1Hydrate forms of alendronate sodium, processes for manufacture thereof, and pharmaceutical compositions thereofTEVA PHARMA·Filed 1999·Granted Aug 28, 2001·18 cites·22 claims
- 1954US2023331762A1Crystalline form of aspacytarabineBIOSIGHT LTD·Filed 2021·Application pending·0 cites
- 2050US2002183378A1Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other formsFiled 2001·Application pending·0 cites
- 2145US2007265456A1Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other formsARONHIME JUDITH·Filed 2006·Application pending·0 cites
- 2243US2002052527A1Novel process for preparing alendronic acidFiled 2001·Application pending·0 cites
- 2341US2002026069A1Process for manufacture of L-DOPA ethyl esterFiled 2001·Application pending·0 cites
- 2438US2004230076A1Process for purification of zoledronic acidFiled 2004·Application pending·0 cites
- 2537US2003135065A1Process for the production of L-DOPA ethyl esterFiled 2002·Application pending·0 cites
- 2637US2002107275A1Novel crystal and solvate forms of ondansetron hydrochloride and processes for their preparationFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ramy Lidor-Hadas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →